The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(5-chloro-1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide ID: ALA4761676
PubChem CID: 141755662
Max Phase: Preclinical
Molecular Formula: C23H20ClN3O
Molecular Weight: 389.89
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCCc1c[nH]c2ccc(Cl)cc12)c1ccccc1Nc1ccccc1
Standard InChI: InChI=1S/C23H20ClN3O/c24-17-10-11-21-20(14-17)16(15-26-21)12-13-25-23(28)19-8-4-5-9-22(19)27-18-6-2-1-3-7-18/h1-11,14-15,26-27H,12-13H2,(H,25,28)
Standard InChI Key: QFRKUURFWZMRAG-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
4.0104 -19.0176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0093 -19.8448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7239 -20.2576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7221 -18.6049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4373 -19.0140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4422 -19.8402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2296 -20.0910 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7114 -19.4196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2217 -18.7541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4721 -17.9680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2779 -17.7919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8334 -18.4016 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6392 -18.2253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1947 -18.8351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8894 -17.4394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9412 -19.6203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4960 -20.2298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3028 -20.0537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5519 -19.2630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9954 -18.6569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1350 -19.7948 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8831 -20.5802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0755 -20.7511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8233 -21.5357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3778 -22.1476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1876 -21.9696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4359 -21.1853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2959 -18.6053 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
16 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
1 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.89Molecular Weight (Monoisotopic): 389.1295AlogP: 5.54#Rotatable Bonds: 6Polar Surface Area: 56.92Molecular Species: NEUTRALHBA: 2HBD: 3#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 6.50CX LogD: 6.50Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.41Np Likeness Score: -1.20
References 1. Fan X,Li J,Deng X,Lu Y,Feng Y,Ma S,Wen H,Zhao Q,Tan W,Shi T,Wang Z. (2020) Design, synthesis and bioactivity study of N-salicyloyl tryptamine derivatives as multifunctional agents for the treatment of neuroinflammation., 193 [PMID:32182488 ] [10.1016/j.ejmech.2020.112217 ]